Meir Goldsmith

2.8k total citations
35 papers, 2.0k citations indexed

About

Meir Goldsmith is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Meir Goldsmith has authored 35 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 12 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Meir Goldsmith's work include RNA Interference and Gene Delivery (22 papers), Advanced biosensing and bioanalysis techniques (11 papers) and Immunotherapy and Immune Responses (8 papers). Meir Goldsmith is often cited by papers focused on RNA Interference and Gene Delivery (22 papers), Advanced biosensing and bioanalysis techniques (11 papers) and Immunotherapy and Immune Responses (8 papers). Meir Goldsmith collaborates with scholars based in Israel, United States and Germany. Meir Goldsmith's co-authors include Dan Peer, Srinivas Ramishetti, Dalit Landesman‐Milo, Nuphar Veiga, Vincent M. Rotello, Daniel F. Moyano, Oscar R. Miranda, Niels Dammes, Ranit Kedmi and Daniel Rosenblum and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

In The Last Decade

Meir Goldsmith

35 papers receiving 2.0k citations

Peers

Meir Goldsmith
Comparison fields: 5 of 104
  • Molecular Biology 1.4k
  • Immunology 462
  • Biomaterials 455
  • Biomedical Engineering 391
  • Genetics 182
Jeonghwan Kim South Korea
Yuriko Higuchi Japan
Sean A. Dilliard United States
Ying‐Li Luo China
Thomas Schluep United States
Xiangang Huang China
Scott Barros United States
Srinivas Ramishetti Israel
Anna Riccioli Italy
Xinyao Du United States
Jeonghwan Kim South Korea View profile →
Citations per field, relative to Meir Goldsmith
Meir Goldsmith · 1×
Citations per year, relative to Meir Goldsmith
Meir Goldsmith · 1×

Countries citing papers authored by Meir Goldsmith

Since Specialization
Citations

This map shows the geographic impact of Meir Goldsmith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meir Goldsmith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meir Goldsmith more than expected).

Fields of papers citing papers by Meir Goldsmith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meir Goldsmith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meir Goldsmith. The network helps show where Meir Goldsmith may publish in the future.

Co-authorship network of co-authors of Meir Goldsmith

This figure shows the co-authorship network connecting the top 25 collaborators of Meir Goldsmith. A scholar is included among the top collaborators of Meir Goldsmith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meir Goldsmith. Meir Goldsmith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 On‐Chip De Novo Production of mRNA Vaccine in Lipid Nanoparticles Small Shai Zilberzwige‐Tal, Aviad Levin et al. 1
2 Low-frequency ultrasound-mediated blood-brain barrier opening enables non-invasive lipid nanoparticle RNA delivery to glioblastoma Journal of Controlled Release Nitay Ad‐El, Meir Goldsmith et al. 4
3 Targeting intestinal inflammation using locked nucleic acids delivered via lipid nanoparticles Nature Communications Gonna Somu Naidu, Meir Goldsmith et al. 2
4 Targeted CRISPR/Cas9 Lipid Nanoparticles Elicits Therapeutic Genome Editing in Head and Neck Cancer Advanced Science Lior Stotsky‐Oterin, Nitay Ad‐El et al. 11
5 Lipid Nanoparticles With Fine‐Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA Therapeutics Advanced Science Riccardo Rampado, Gonna Somu Naidu et al. 10
6 A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA Delivery Advanced Science Gonna Somu Naidu, Seok‐Beom Yong et al. 73
7 Delivery of Therapeutic RNA to the Bone Marrow in Multiple Myeloma Using CD38‐Targeted Lipid Nanoparticles (Adv. Sci. 21/2023) Advanced Science Inbal Hazan‐Halevy, Meir Goldsmith et al. 2
8 A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium Science Advances Edo Kon, Yinon Levy et al. 61
9 Delivery of Therapeutic RNA to the Bone Marrow in Multiple Myeloma Using CD38‐Targeted Lipid Nanoparticles Advanced Science Inbal Hazan‐Halevy, Meir Goldsmith et al. 35
10 Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticles Journal of Controlled Release Meir Goldsmith, Srinivas Ramishetti et al. 41
11 Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics Nature Nanotechnology Niels Dammes, Meir Goldsmith et al. 122
12 Bioinspired artificial exosomes based on lipid nanoparticles carrying let-7b-5p promote angiogenesis in vitro and in vivo Molecular Therapy Sezin Aday, Inbal Hazan‐Halevy et al. 57
13 Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory target Journal of Controlled Release Nuphar Veiga, Meir Goldsmith et al. 46
14 Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes Nature Communications Nuphar Veiga, Meir Goldsmith et al. 249
15 Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles ACS Nano Srinivas Ramishetti, Ranit Kedmi et al. 160
16 Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells Cancer Letters Dalit Landesman‐Milo, Meir Goldsmith et al. 55
17 Assessing cellular toxicities in fibroblasts upon exposure to lipid-based nanoparticles: a high content analysis approach Nanotechnology Leonardo J. Solmesky, Meir Goldsmith et al. 20
18 A ceramide analog inhibits cPLA2 activity and consequent PGE2 formation in LPS-stimulated macrophages Immunology Letters Meir Goldsmith, Nadia F. Lamour et al. 16
19 Synergistic IL-10 induction by LPS and the ceramide-1-phosphate analog PCERA-1 is mediated by the cAMP and p38 MAP kinase pathways Molecular Immunology Meir Goldsmith, Dorit Avni et al. 29
20 A ceramide‐1‐phosphate analogue, PCERA‐1, simultaneously suppresses tumour necrosis factor‐α and induces interleukin‐10 production in activated macrophages Immunology Meir Goldsmith, Dorit Avni et al. 34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026